Skip to main content
. 2019 Sep 16;20(18):4575. doi: 10.3390/ijms20184575

Table 3.

Relative reversal of doxorubicin (DOX) and paclitaxel (PTX) resistance in NCI-H460/R and DLD1-TxR cells induced by Hsp90 inhibitor.

Compound DOX IC50 (nM) Relative Reversal
DOX 2265.6 ± 42.4
5
2.5 µM 1731.4 ± 30.9 1.31
5 µM 863.9 ± 25.6 2.62
10 µM 429 ± 13.3 5.28
PTX 1528.5 ± 48.6
5
1 µM 850.4 ± 13.1 1.80
2.5 µM 588.3 ± 12.0 2.60
5 µM 290.0 ± 5.0 5.27